Most lately, it's been discovered that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to some big range of endogenous opioids. In contrast to most opioid receptors, this receptor acts for a scavenger https://johnx691vws2.activosblog.com/profile